drugset / Trial / NCT02623114
Attention-deficit/Hyperactivity Disorder Translational Center for Identifying Biomarkers
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study was to identify genetic, brain morphologic, and environmental biomarkers that contribute to the pathophysiology of attention-deficit/hyperactivity disorder (ADHD).
Timeline
- Start
- 2012-05
- Primary completion
- 2016-08
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atomoxetine | Other / unclassified | — | — |
| Subject | Methylphenidate | Small molecule | — | — |